Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Class H Shares

HKSE:06990 (China)   Class H Shares
HK$ 196.70 (+4.02%) Oct 23
At Loss
P/B:
12.69
Market Cap:
HK$ 43.83B ($ 5.64B)
Enterprise V:
HK$ 40.71B ($ 5.24B)
Volume:
294.94K
Avg Vol (2M):
558.86K
Warning! GuruFocus detected 4 Good signs with 06990. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
294.94K
Market Cap HK$:
43.83B
Market Cap $:
5.64B
At Loss
Avg Vol (2M):
558.86K
Enterprise Value HK$:
40.71B
Enterprise Value $:
5.24B
PB Ratio:
12.69
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

ISIN : CNE1000062J1
http://www.kelun-biotech.com
No. 666 Xinhua Avenue, Chengdu Cross-Strait Science and Technology Industry Development Park, Wenjiang, Sichuan, Chengdu, CHN

Share Class Description:

HKSE:06990: Class H Shares
Compare
Compare
HKSE:01530HKSE:02162HKSE:06826HKSE:09969HKSE:01541HKSE:09966HKSE:06660HKSE:01952HKSE:02105HKSE:02315OCSE:NOVO BVRTXREGNASX:CSLSGENXKRX:207940MRNAXBRU:ARGXHKSE:02269BNTX
Traded in other countries / regions
06990.Hong Kong
IPO Date
2023-07-11
Description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.

Financial Strength

9/10
Name Current Vs Industry Vs History
Cash-To-Debt 75.77
Equity-to-Asset 0.84
Debt-to-Equity 0.01
Debt-to-EBITDA -0.42
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 19.03
Distress
Grey
Safe
Beneish M-Score -3.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate 13.61

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 62.4
9-Day RSI 58.27
14-Day RSI 57.73
6-1 Month Momentum % 17.73
12-1 Month Momentum % 139.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.7
Quick Ratio 5.59
Cash Ratio 5.23
Days Inventory 36.51
Days Sales Outstanding 2.17
Days Payable 178.6

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -0.82

Profitability Rank

1/10
Name Current Vs Industry Vs History
Gross Margin % 61.62
Operating Margin % -10.19
Net Margin % -12.81
FCF Margin % -30.46
ROE % -14.37
ROA % -7.24
ROIC % -22.82
ROC (Joel Greenblatt) % -15.08
ROCE % -5.71

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 21.29
PB Ratio 12.69
Price-to-Tangible-Book 12.7
EV-to-EBIT -363.49
EV-to-Forward-EBIT -36.27
EV-to-EBITDA -401.64
EV-to-Revenue 19.22
EV-to-Forward-Revenue 34.47
EV-to-FCF -64.53
Price-to-Net-Current-Asset-Value 16.08
Price-to-Net-Cash 17.91
Earnings Yield (Greenblatt) % -0.28
FCF Yield % -1.41

Financials

HKSE:06990's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Executives

Details

GF Value

HKSE:06990

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 2,029.254
EPS (TTM) (HK$) -0.961
Beta 0
Volatility % 58.58
14-Day RSI 57.73
14-Day ATR (HK$) 12.827601
20-Day SMA (HK$) 188.615
12-1 Month Momentum % 139.83
52-Week Range (HK$) 63.65 - 223.8
Shares Outstanding (Mil) 222.84

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Frequently Asked Questions

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)'s stock price today?
The current price of HKSE:06990 is HK$196.70. The 52 week high of HKSE:06990 is HK$223.80 and 52 week low is HK$63.65.
When is next earnings date of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)?
The next earnings date of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) is .
Does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) pay dividends? If so, how much?
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.